CorMedix (CRMD) EBIAT: 2012-2025
Historic EBIAT for CorMedix (CRMD) over the last 12 years, with Sep 2025 value amounting to $108.6 million.
- CorMedix's EBIAT rose 4009.63% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.5 million, marking a year-over-year increase of 495.00%. This contributed to the annual value of -$17.9 million for FY2024, which is 61.31% up from last year.
- As of Q3 2025, CorMedix's EBIAT stood at $108.6 million, which was up 447.52% from $19.8 million recorded in Q2 2025.
- CorMedix's EBIAT's 5-year high stood at $108.6 million during Q3 2025, with a 5-year trough of -$14.5 million in Q1 2024.
- In the last 3 years, CorMedix's EBIAT had a median value of -$6.3 million in 2023 and averaged $10.0 million.
- Its EBIAT has fluctuated over the past 5 years, first crashed by 64.15% in 2022, then surged by 4,009.63% in 2025.
- CorMedix's EBIAT (Quarterly) stood at -$7.8 million in 2021, then dropped by 5.36% to -$8.2 million in 2022, then slumped by 42.18% to -$9.7 million in 2023, then surged by 71.50% to $13.5 million in 2024, then surged by 4,009.63% to $108.6 million in 2025.
- Its EBIAT was $108.6 million in Q3 2025, compared to $19.8 million in Q2 2025 and $20.6 million in Q1 2025.